Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases
关注订阅预警-> 医药魔方数据库2021-06-23
Adela’s Series A financing round was led by F-Prime Capital with OrbiMed, Deerfield Management, Decheng Capital, and RA Capital Management participating.
（以上内容由医药魔方AI生成）
资讯来源：全球通
查看原文
阅读 494